BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25416449)

  • 21. Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways.
    Wu C; Chen M; Sun Z; Ye Y; Han X; Qin Y; Liu S
    J Ethnopharmacol; 2019 Mar; 232():145-154. PubMed ID: 30576770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
    Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
    Fong JE; Le Nihouannen D; Komarova SV
    J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
    Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
    Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathways.
    Wang H; Shen W; Hu X; Zhang Y; Zhuo Y; Li T; Mei F; Li X; Xiao L; Chu T
    Breast Cancer Res Treat; 2015 Feb; 149(3):705-14. PubMed ID: 25667102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
    Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
    Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro.
    Chikatsu N; Takeuchi Y; Tamura Y; Fukumoto S; Yano K; Tsuda E; Ogata E; Fujita T
    Biochem Biophys Res Commun; 2000 Jan; 267(2):632-7. PubMed ID: 10631114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.
    Pollari S; Käkönen SM; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
    Breast Cancer Res Treat; 2011 Jan; 125(2):421-30. PubMed ID: 20352489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells.
    Chiovaro F; Martina E; Bottos A; Scherberich A; Hynes NE; Chiquet-Ehrismann R
    Int J Cancer; 2015 Oct; 137(8):1842-54. PubMed ID: 25868708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
    Yamaguchi M
    Mol Cell Biochem; 2016 Oct; 421(1-2):193-203. PubMed ID: 27573001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
    Yadav B; Taurin S; Larsen L; Rosengren RJ
    Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.
    Dedes PG; Kanakis I; Gialeli Ch; Theocharis AD; Tsegenidis T; Kletsas D; Tzanakakis GN; Karamanos NK
    Biochim Biophys Acta; 2013 Jun; 1830(6):3625-34. PubMed ID: 23395844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of breast cancer metastasis to the lungs with UBS109.
    Shoji M; Qian WP; Nagaraju GP; Brat DJ; Pessolano D; Luzietti R; Chennamadhavuni S; Yamaguchi M; Yang L; Liotta DC
    Oncotarget; 2018 Nov; 9(90):36102-36109. PubMed ID: 30546830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biselyngbyaside, isolated from marine cyanobacteria, inhibits osteoclastogenesis and induces apoptosis in mature osteoclasts.
    Yonezawa T; Mase N; Sasaki H; Teruya T; Hasegawa S; Cha BY; Yagasaki K; Suenaga K; Nagai K; Woo JT
    J Cell Biochem; 2012 Feb; 113(2):440-8. PubMed ID: 21678460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic interaction between breast cancer cells and osteoblastic tissue: comparison of two- and three-dimensional cultures.
    Krishnan V; Shuman LA; Sosnoski DM; Dhurjati R; Vogler EA; Mastro AM
    J Cell Physiol; 2011 Aug; 226(8):2150-8. PubMed ID: 21520067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. δEF1 promotes osteolytic metastasis of MDA-MB-231 breast cancer cells by regulating MMP-1 expression.
    Hu F; Wang C; Guo S; Sun W; Mi D; Gao Y; Zhang J; Zhu T; Yang S
    Biochim Biophys Acta; 2011 Mar; 1809(3):200-10. PubMed ID: 21241837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular mechanisms of bone resorption in breast carcinoma.
    Hunt NC; Fujikawa Y; Sabokbar A; Itonaga I; Harris A; Athanasou NA
    Br J Cancer; 2001 Jul; 85(1):78-84. PubMed ID: 11437406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling.
    Hsieh CJ; Kuo PL; Hou MF; Hung JY; Chang FR; Hsu YC; Huang YF; Tsai EM; Hsu YL
    Int J Oncol; 2015 Feb; 46(2):555-62. PubMed ID: 25421824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of low intensity pulsed ultrasound on osteoclastogenesis induced in vitro by breast cancer cells.
    Carina V; Costa V; Pagani S; De Luca A; Raimondi L; Bellavia D; Setti S; Fini M; Giavaresi G
    J Exp Clin Cancer Res; 2018 Aug; 37(1):197. PubMed ID: 30126457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.